Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arginine Therapy for the Treatment of Vaso-Occlusive Events in Children With Severe Sickle Cell Disease

NCT02447874 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02447874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02447874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arginine Therapy for the Treatment of Vaso-Occlusive Events in Children With Severe Sickle Cell Disease
Lead sponsor
Emory University
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 31, 2015
Completion date
January 31, 2028
Enrollment
21 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease